期刊文献+

p53、p21^(ras)和connexin43蛋白在卵巢浆液性囊腺癌中的表达及意义 被引量:8

下载PDF
导出
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2006年第4期498-499,共2页 Chinese Journal of Clinical and Experimental Pathology
  • 相关文献

参考文献13

  • 1Kern S E,Kinzler K W,Bruskin A,et al.Identification of p53 as a sequence-specific DNA-binding protein[J].Science,1991,252(5013):11708-11711.
  • 2刘履光,杨坤禹.C-erbB2、nm23和p53蛋白在卵巢上皮性癌中的表达及其临床意义[J].中华妇产科杂志,1999,34(2):101-104. 被引量:12
  • 3Chan W Y,Cheung K K,Schorge J O,et al.Bcl-2 and p53 protein expression,apoptosis,and p53 mutation in human epithelial ovarian cancers[J].Am J Pathol,2000,156(2):409-417.
  • 4Morita K,Ono Y,Fukui H,et al.Incidence of p53 and K-ras alterations in ovarian mucinous and serous tumors[J].Pathol Int,2000,50(3):219-223.
  • 5潘晓琳,高志斌,陆天才,李洪安,郑兴征.卵巢癌中k-ras基因点突变及p53蛋白表达[J].临床与实验病理学杂志,2005,21(1):66-69. 被引量:15
  • 6Orsulic S,Li Y,Soslow R A,et al.Induction of ovarian cancer by defined multiple genetic changes in a mouse model system[J].Cancer Cell,2002,1(1):53-62.
  • 7Yaginuma Y,Yamashita K,Kuzumaki N,et al.Ras oncogene product p21 expression and prognosis of human ovarian tumors[J].Gynecol Oncol,1992,46(1):45-50.
  • 8Harlozinska A,Bar J K,Sobanska E,et al.p53,c-erbB-2 and p21ras expression in tumor effusion cells of patients with histopathologically different ovarian neoplasms[J].Anticancer Res,1997,17(5A):3545-3552.
  • 9Umhauer S,Ruch R J,Fanning J,et al.Gap junctional intercellular communication and connexin 43 expression in ovarian carcinoma[J].Am J Obstet Gynecol,2000,182(5):999-1000.
  • 10Hossain M Z,Jagdale A B,Ao P,et al.Impaired expression and posttranslational processing of connexin43 and downregulation of gap junctional communication in neoplastic human prostate cells[J].Prostate,1999,38(1):55-59.

二级参考文献18

  • 1卢欣 李春海 等.抗癌基因p53 C-erbB2.肿瘤分子生物学研究进展[M].北京:军事医学科学出版社,1996.57-59.
  • 2卢欣,肿瘤分子生物学研究进展,1996年,57页
  • 3余松林,临床随访资料的统计分析方法,1991年,10页
  • 4Qian M,Chin Med J,1997年,110卷,142页
  • 5Jiang W,Kahn SM,Guillem JG,et al. Rapid detection of ras oncogenes in human tumors: applications to colon,esophageal,and gastric cancer[J]. Oncogene,1989,4(7): 923-8.
  • 6Yanagisawa A,Ohtake K,Ohashi K, et al. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation[J]. Cancer Res,1993,53(5): 953-6.
  • 7Fujita M,Enomoto T,Murata Y. Genetic alterations in ovarian carcinoma: with specific reference to histological subtypes[J]. Mol Cell Endocrinol,2003,202(1-2):97-9.
  • 8Mandai M,Konoshi I,Kuroda H,et al. Heterogeneous distribution of k-ras mutated epithelia in mucinous ovarian tumors with special reference to histopathology[J]. Hum Pathol,1998,29(1):34-40.
  • 9Pellegata NS,Sessa F,Renault B,et al. k-ras and p53 gene mutation in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions[J]. Cancer Res,1994,54(6):1556-60.
  • 10Maeshima A,Miyagi A,Hirai T,et al. Mucin-producing adenocarcinoma of the lung,with special reference to goblet cell type adenocarcinoma: immunohistochemical observation and Ki-ras gene mutation[J]. Pathol Int,1997,47(7):454-60.

共引文献25

同被引文献72

引证文献8

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部